A watchlist is not a point of view.
Market and competitive intelligence platforms are strong at surveillance: tracking competitors, news, and mentions, then alerting you. Signals starts where the alert ends: turning weak signals of change into structured research about where things are heading.
- Today: teams monitor competitors, keywords, news, and alerts.
- Problem: the feed still leaves someone to decide what matters.
- Signals checks every source, then turns the findings into a view your team can act on.
Reach for a market or competitive intelligence platform when
- Your core need is real-time monitoring and alerting on known entities.
- You're tracking named competitors, keywords, or social mentions.
- You want a feed, dashboard, and notifications more than a research record.
Reach for Signals when
- You're chasing weak, emergent signals beyond news about known players.
- You need every signal grounded in judged sources before it reaches a briefing.
- The output has to be a synthesis your team can review, not a stream of items.
| Market intel tools | Signals | |
|---|---|---|
| Posture | Backward-looking surveillance of what already happened. | Forward-looking foresight on emerging signals of change. |
| Output | Feeds, dashboards, and alerts. | Structured Signals with grounding states, Frames, and narrative Reports. |
| Evidence handling | Items are surfaced; relevance is left to the reader. | Each Source is judged supports / contradicts / unrelated / unreachable. |
| Synthesis | You assemble meaning from the feed yourself. | Frames and Reports synthesize signals into a view your team can inspect. |
| Scope | Tuned to known entities and keywords. | Scoped by a research briefing, open-ended by design. |
| Continuity | A rolling stream; little structural memory. | Sessions stack inside a Workspace so the theme accumulates structure. |
A question a buyer would bring
"What early signals of change are emerging around solid-state batteries?"
Run this as a free scan →And here’s what an answer looks like.
A real finding from a recent run, merged where models agreed, scored, dated, and tied back to sources.
What is changing across AI-driven drug discovery platforms, GLP-1 follow-ons, and the shifting economics of clinical trials?
Synthetic Control Arm Adoption
Keep the monitoring tool for the watchlist. Use Signals when someone has to decide what the watchlist means.
Other comparisons
“ Signals research made my year! ”
Arijana Drinic
Head of Exploration
Test Signals against market intel tools.
Bring the question you would normally put into a chat, report brief, or consulting kickoff.